Pancreatic Cancer Research

ResearcherJikei University School of MedicineActive in the last 2 years

Masayuki Saruta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8172-3240; OpenAlex author ID A5054899877, A5101118131. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
30
Papers, trials and grants by year

2018: 1 paper · 2019: 6 papers · 2020: 3 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 14

  1. Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide… Co-author DOI 10.1136/jitc-2024-011426↗
  2. Dendritic cells pulsed with multifunctional Wilms' tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable … Co-author DOI 10.1136/jitc-2024-009765↗
  3. [A case of advanced pancreatic cancer with oculomotor nerve palsy caused by herpes zoster after introduction of gemcitabine plus nab-paclitaxel]. Last author DOI 10.11405/nisshoshi.118.86↗
  4. Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-021-08911-4↗
  5. Splenic artery pseudoaneurysm following chemotherapy in a patient with pancreatic cancer: a case report. Co-author DOI 10.1007/s12328-020-01137-0↗
  6. The Diverse Involvement of Cigarette Smoking in Pancreatic Cancer Development and Prognosis. Last author DOI 10.1097/mpa.0000000000001550↗
  7. Cancerous pericarditis presenting as cardiac tamponade in a 68-year-old man with pancreatic adenocarcinoma: a case report. Co-author DOI 10.1186/s13256-020-02546-y↗
  8. Photoimmunotherapy targeting biliary-pancreatic cancer with humanized anti-TROP2 antibody. Co-author DOI 10.1002/cam4.2658↗
  9. The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients. Last author DOI 10.1007/s00280-019-03895-2↗
  10. Clinical Significance of Tumor-Infiltrating T Cells and Programed Death Ligand-1 in Patients with Pancreatic Cancer. Co-author DOI 10.1080/07357907.2019.1661427↗
  11. Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1. Co-author DOI 10.1159/000500359↗
  12. The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer. Last author DOI 10.3390/ijms20133331↗
  13. Pancreatic cancer screening in patients with presumed branch-duct intraductal papillary mucinous neoplasms. Last author DOI 10.5306/wjco.v10.i2.67↗
  14. Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2018.8961↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigeo Koido · 8 shared papers, 2018–2025 · strength 0.95
  2. Zensho Ito · 7 shared papers, 2018–2025 · strength 0.84
  3. Haruo Sugiyama · 6 shared papers, 2018–2025 · strength 0.72
  4. Toshifumi Ohkusa · 4 shared papers, 2019–2025 · strength 0.57
  5. Shigetaka Shimodaira · 4 shared papers, 2018–2025 · strength 0.53
  6. Shin Kan · 4 shared papers, 2019–2024 · strength 0.44
  7. Kazuki Takakura · 4 shared papers, 2018–2020 · strength 0.44
  8. Masamori Shimabuku · 2 shared papers, 2024–2025 · strength 0.38
  9. Shuichi Fujioka · 3 shared papers, 2018–2021 · strength 0.25
  10. Yuichi Torisu · 2 shared papers, 2019 · strength 0.23
  11. Sachie Kiryu · 2 shared papers, 2020–2021 · strength 0.23
  12. Masato Okamoto · 3 shared papers, 2018–2019 · strength 0.23
  13. Utako Ishimoto · 2 shared papers, 2019–2021 · strength 0.22
  14. Kazuhiko Koike · 2 shared papers, 2019–2021 · strength 0.22
  15. Yuki Hirose · 2 shared papers, 2019–2021 · strength 0.22
  16. Shintaro Tsukinaga · 1 shared paper, 2024 · strength 0.18
  17. Sayumi Yoshida · 2 shared papers, 2019 · strength 0.16
  18. Simcha I Weissman · 1 shared paper, 2020 · strength 0.15
  19. Stephen Jacob Pandol · 1 shared paper, 2020 · strength 0.15
  20. Guido Eibl · 1 shared paper, 2020 · strength 0.15
  21. Mikio Kajihara · 2 shared papers, 2018–2019 · strength 0.15
  22. Yoshihiro Shirai · 1 shared paper, 2020 · strength 0.13
  23. Kenei Furukawa · 1 shared paper, 2020 · strength 0.13
  24. Hiroaki Shiba · 1 shared paper, 2020 · strength 0.13
  25. Katsuhiko K. Yanaga · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.